Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF and NAC in Severe Alcoholic Hepatitis
NCT05840640Phase 4Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Oct 2017
- Primary completion
- Feb 2021
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of filgrastim, acetylcysteine in alcoholic hepatitis (AH), sponsored by Post Graduate Institute of Medical Education and Research. Started Oct 2017; status: completed.
02
Drugs
filgrastimacetylcysteine
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT05840640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05840640.